-
A New Era in Molecular Subtyping of Aggressive B-cell Lymphoma: Professor David W. Scott on Genomics-Guided Precision Therapy丨EHA 2025
Current Status and Challenges in the Classification of Aggressive B-cell Lymphoma “The classification systems we currently use, whether the International Consensus Classification (ICC) or the 5th edition of the World…
-
The Journey of Disease Discovery: Professor Elaine Jaffe Reviews a Century of Lymphoma Diagnosis and Classification
The Microscope: An Enduring Tool for Disease Discovery and Rudolf Virchow’s Legacy In today’s rapidly advancing modern medicine, despite the rapid development of molecular biology techniques, the microscope, as a…
-
Professor Bruce D. Cheson on Breakthroughs in Lymphoma Treatment: Innovation Pathways and Future Vision丨EHA 2025
Dreams, Luck, and a Little Bit of Crazy – The Transformative Journey of Lymphoma Treatment Professor Cheson began his speech by emphasizing that to foresee the future, one must first…
-
Professor Yuzhu Shi: The Comprehensive Value of Abdominal CT in Managing Post-Transplant Complications丨13th Lu Daopei Hematology Conference
PART 1 Abdominal complications are a major challenge in post-HSCT management. Compared with other imaging modalities or laboratory tests, what do you consider the unique advantages and core clinical value…
-
Professor Hui Wang: Advancing MRD Detection in AML—From Standardization and Automation Toward Personalized Treatment
PART 1 MRD monitoring plays a vital role in prognosis and guiding individualized treatment strategies in AML. What do you consider the most significant advances in flow cytometry for MRD…
-
Professor Tong Wang Analyzes the Clinical Challenges of Multilineage Involvement in BCR::ABL1-Positive B-ALL丨13th Lu Daopei Hematology Conference
PART 1 At both the EHA meeting and this conference, you focused on multilineage-involved BCR::ABL1-positive B-ALL. Could you share the motivation and clinical background for this study? How common are…
-
Professor Jianping Zhang: Optimizing Indication Selection, Timing, and Technical Innovations in Pediatric SAA Transplantation丨13th Lu Daopei Hematolog
PART 1 Your center has accumulated extensive experience with pediatric severe aplastic anemia. Compared with traditional immunosuppressive therapy, what key standards guide your team’s selection of transplant indications? Could you…
-
Professor Daniel Hartson Provides In-depth Analysis of DLBCL’s Genetic Complexity and Innovative Research Models丨EHA 2025
In 2025, the highly anticipated 30th European Hematology Association (EHA) Annual Congress was grandly held in Milan, Italy. This conference brought together top experts and scholars from around the world to discuss cutting-edge topics in basic research and clinical translation in the field of hematolog.Professor Daniel Hartson from the University of Cambridge delivered an insightful…
Connecting Medical Expertise through Media